Enhanced antibiotic activity of ampicillin conjugated to gold nanoparticles on PEGylated rosette nanotubes
Yiwen Fan,Alexander C Pauer,Arthur A Gonzales,Hicham Fenniri
DOI: https://doi.org/10.2147/IJN.S209756
IF: 7.033
2019-11-25
International Journal of Nanomedicine
Abstract:Yiwen Fan 1 , Alexander C Pauer 1 , Arthur A Gonzales 1 , Hicham Fenniri 1–3 1 Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USA; 2 Department of Bioengineering, Northeastern University, Boston, MA 02115, USA; 3 Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA Correspondence: Hicham Fenniri Department of Chemical Engineering, Northeastern University, 360 Huntington Avenue, Boston, MA 02115, USA Tel +1 617 373 7690 Fax +1 617 373 2209 Email h.fenniri@northeastern.edu Purpose: This work presents the preparation of a nanocomposite of ampicillin-conjugated gold nanoparticles (AuNPs) and self-assembled rosette nanotubes (RNTs), and evaluates its antibacterial properties against two strains of drug-resistant bacteria ( Staphylococcus aureus [ S. aureus ], methicillin-resistant S. aureus [MRSA]). Materials and methods: Small, nearly monodisperse AuNPs (1.43±0.5 nm in diameter) nucleated on the surface of polyethylene glycol-functionalized RNTs in a one-pot reaction. Upon conjugation with ampicillin, their diameter increased to 1.86±0.32 nm. The antibacterial activity of the nanocomposite against S. aureus and MRSA was tested using different concentrations of ampicillin. The cytocompatibility of the nanocomposite was also tested against human dermal fibroblasts. Results: Based on bacterial inhibition studies, the nanocomposite demonstrated enhanced antibiotic activity against both bacterial strains. The minimum inhibitory concentration (MIC) of the nanocomposite against S. aureus was found to be 0.58 μg/mL, which was 18% lower than ampicillin alone. The nanocomposite also exhibited a 20 hrs MIC of 4 μg/mL against MRSA, approximately 10–20 times lower than previously reported values for ampicillin alone. In addition, at concentrations of 4 μg/mL of ampicillin (70 μg/mL of AuNPs), the nanocomposite showed negligible cytotoxic effects. Conclusion: Our findings offer a new approach for the treatment of drug-resistant bacteria by potentiating inhibitory effects of existing antibiotics, and delivering them using a non-toxic formulation. Keywords: ampicillin, rosette nanotubes, gold nanoparticles, S. aureus , methicillin-resistant S. aureus
pharmacology & pharmacy,nanoscience & nanotechnology